Med Paper Statistics

Total Valuation

Med Paper has a market cap or net worth of MAD 99.74 million. The enterprise value is 293.35 million.

Market Cap	99.74M
Enterprise Value	293.35M

Important Dates

The next estimated earnings date is Thursday, June 26, 2025.

Earnings Date	Jun 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Med Paper has 4.78 million shares outstanding. The number of shares has decreased by -1.23% in one year.

Current Share Class	4.78M
Shares Outstanding	4.78M
Shares Change (YoY)	-1.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 12.34.

PE Ratio	12.34
Forward PE	n/a
PS Ratio	0.94
PB Ratio	2.90
P/TBV Ratio	n/a
P/FCF Ratio	8.22
P/OCF Ratio	7.38
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.96, with an EV/FCF ratio of 24.19.

EV / Earnings	36.74
EV / Sales	2.78
EV / EBITDA	39.96
EV / EBIT	47.26
EV / FCF	24.19

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 5.64.

Current Ratio	0.96
Quick Ratio	0.70
Debt / Equity	5.64
Debt / EBITDA	26.50
Debt / FCF	16.03
Interest Coverage	1.88

Financial Efficiency

Return on equity (ROE) is 26.23% and return on invested capital (ROIC) is 1.67%.

Return on Equity (ROE)	26.23%
Return on Assets (ROA)	1.11%
Return on Invested Capital (ROIC)	1.67%
Return on Capital Employed (ROCE)	3.87%
Revenue Per Employee	233,033
Profits Per Employee	17,627
Employee Count	453
Asset Turnover	0.30
Inventory Turnover	1.06

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.47% in the last 52 weeks. The beta is -0.19, so Med Paper's price volatility has been lower than the market average.

Beta (5Y)	-0.19
52-Week Price Change	+4.47%
50-Day Moving Average	21.96
200-Day Moving Average	21.74
Relative Strength Index (RSI)	45.87
Average Volume (20 Days)	11,641

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Med Paper had revenue of MAD 105.56 million and earned 7.99 million in profits. Earnings per share was 1.69.

Revenue	105.56M
Gross Profit	48.95M
Operating Income	6.20M
Pretax Income	8.26M
Net Income	7.99M
EBITDA	7.33M
EBIT	6.20M
Earnings Per Share (EPS)	1.69

Full Income Statement

Balance Sheet

The company has 762,388 in cash and 194.37 million in debt, giving a net cash position of -193.60 million or -40.47 per share.

Cash & Cash Equivalents	762,388
Total Debt	194.37M
Net Cash	-193.60M
Net Cash Per Share	-40.47
Equity (Book Value)	34.43M
Book Value Per Share	7.20
Working Capital	-7.54M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.52 million and capital expenditures -1.40 million, giving a free cash flow of 12.13 million.

Operating Cash Flow	13.52M
Capital Expenditures	-1.40M
Free Cash Flow	12.13M
FCF Per Share	2.54

Full Cash Flow Statement

Margins

Gross margin is 46.37%, with operating and profit margins of 5.87% and 7.56%.

Gross Margin	46.37%
Operating Margin	5.87%
Pretax Margin	7.83%
Profit Margin	7.56%
EBITDA Margin	6.95%
EBIT Margin	5.87%
FCF Margin	11.49%

Dividends & Yields

Med Paper does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.23%
Shareholder Yield	1.23%
Earnings Yield	8.01%
FCF Yield	12.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Med Paper has an Altman Z-Score of 0.46. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.46
Piotroski F-Score	n/a